Neurovascular Devices Market to Grow from USD 4.64 Billion in 2025 to USD 7.22 Billion by 2030, at a CAGR of 9.3%– MarketsandMarkets™

Delray Beach, FL, Aug. 17, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global neurovascular devices market will grow from USD 4.64 billion in 2025 to USD 7.22 billion by 2030, at a CAGR of 9.3% during the forecast period. Market growth is fueled by the rising prevalence of neurovascular diseases, increasing aging populations, hypertension, smoking, and sedentary lifestyles, along with the growing demand for advanced diagnostic and treatment solutions for conditions such as stroke, brain aneurysms, and arteriovenous malformations.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847

Key Market Highlights

• Market size, 2025: USD 4.64 billion
• Market forecast, 2030: USD 7.22 billion
• Growth rate: CAGR of 9.3% (2025–2030)
• Fastest-growing region: Asia Pacific
• Largest disease pathology segment: Cerebral aneurysms
• Largest end-user segment: Hospitals & ambulatory surgical centers
• Key growth opportunity: Advancement of AI- and robot-assisted systems for next-generation neurointerventions
• Key players: Stryker (US), Medtronic (Ireland), Johnson & Johnson (US), Terumo Corporation (Japan), Penumbra (US), MicroPort Scientific Corporation (China), Balt Group (France), Kaneka Corporation (Japan), Phenox GmbH (Wallaby Medical), Asahi Intecc Co., Ltd (Japan), and Achieva Medical (Peijia Medical) (China).

Why This Market Matters

The rising incidence of neurovascular diseases is significantly driving demand for advanced diagnostic and treatment solutions. Conditions such as stroke, brain aneurysms, and arteriovenous malformations require timely diagnosis and minimally invasive interventions. According to the Brain Aneurysm Foundation (2024), an estimated 6.8 million people in the United States live with an unruptured brain aneurysm, while around 30,000 people in the US experience a rupture each year. Globally, brain aneurysms cause nearly 500,000 deaths annually.

The expansion of healthcare infrastructure across emerging economies is also enabling broader adoption of neurointerventional technologies and helping bridge gaps in specialized care.

Market Overview

The neurovascular devices market operates within a dynamic environment shaped by competition, changing healthcare needs, and regulatory challenges. Manufacturers and technology partners are developing advanced products such as stent retrievers, embolic coils, flow diverters, aspiration systems, and microcatheters to enhance procedural accuracy and patient outcomes in stroke and aneurysm treatment. Hospitals, surgical centers, and specialty neurology clinics remain key end users, supported by the growing use of minimally invasive neurointerventional procedures.

Analyst Perspective

The rapid advancement of AI- and robot-assisted systems presents a transformative opportunity for the neurovascular devices market. AI algorithms support preoperative planning, risk assessment, and real-time decision-making, while robotic systems offer highly controlled, minimally invasive navigation. These technologies can improve precision, accuracy, safety, procedural efficiency, and patient outcomes. AI and robotic integration can also help address limitations caused by the shortage of highly skilled neurosurgeons and create opportunities for remote and tele-guided procedures.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=847

Segment Analysis

By disease pathology, the global neurovascular devices market is divided into cerebral aneurysms, ischemic strokes, carotid artery stenosis, arteriovenous malformation & fistulas, and other disease pathologies. The cerebral aneurysms segment held the largest market share. The high rate of cerebral aneurysms is associated with lifestyle, physiological, and genetic factors, including chronic hypertension, smoking, atherosclerosis, alcohol consumption, sedentary lifestyles, age, gender, family history, and genetic disorders.

By end user, the global neurovascular devices market is segmented into hospitals & ambulatory surgical centers, specialty clinics, and research & academic institutes. Hospitals & ambulatory surgical centers are expected to garner the highest share in the market due to their latest diagnostic tools, experienced medical teams, specialized care capabilities, continuous monitoring, rehabilitation services, and ability to manage complications associated with critical conditions such as strokes, aneurysms, and vascular malformations.

Regional Analysis

Asia Pacific is expected to experience the fastest growth during the forecast period. Growth in the region is driven by rapid healthcare improvements, increasing awareness of neurological conditions, rising rates of stroke and cerebral aneurysm, a growing aging population, and lifestyle-related risk factors such as hypertension and diabetes. Governments in China, India, and Japan are investing in hospital infrastructure and increasing access to minimally invasive neurosurgical care.

Key Industry Trends

• Rising incidence of neurovascular diseases
• Expansion of healthcare infrastructure across emerging economies
• Increasing demand for minimally invasive neurointerventional procedures
• Advancement of AI- and robot-assisted systems
• Growing adoption of sophisticated neurovascular devices
• Increasing opportunities for remote and tele-guided procedures
• Ongoing investment in research and development within the neurovascular sector.

Competitive Landscape

The competitive landscape of the neurovascular devices market includes leading multinational corporations and regional players. Prominent players include Stryker, Johnson & Johnson, Medtronic, Terumo Corporation, and Penumbra. Other companies include MicroPort Scientific Corporation, Balt Group, Kaneka Corporation, Phenox GmbH (Wallaby Medical), Asahi Intecc Co., Ltd, and Achieva Medical (Peijia Medical).

Key players have adopted a combination of organic and inorganic growth strategies, including product launches, acquisitions, collaborations, partnerships, agreements, and expansions to strengthen their global presence and increase market share.

Related Reports
Peripheral Vascular Devices Market
Interventional Cardiology Devices Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Report Code: MD 1310 | Published: 6 November 2025 | Report Pages: 450 | Market Data Tables: 350 | Figures: 223